The second pandemic: Examining structural inequality through reverberations of COVID-19 in Europe.

COVID-19 Europe Health Pandemic Structural inequality Wealth

Journal

Social science & medicine (1982)
ISSN: 1873-5347
Titre abrégé: Soc Sci Med
Pays: England
ID NLM: 8303205

Informations de publication

Date de publication:
01 2022
Historique:
received: 31 05 2021
revised: 21 10 2021
accepted: 02 12 2021
pubmed: 10 12 2021
medline: 14 1 2022
entrez: 9 12 2021
Statut: ppublish

Résumé

While everyone has been impacted directly or indirectly by the COVID-19 pandemic and the measures to contain it, not everyone has been impacted in the same way and certainly not to the same degree. Media coverage in early 2020 emphasized the "unprecedented" nature of the pandemic, and some even predicted that the virus could be a global "equalizer." Ensuing debates over how the pandemic should be handled have often hinged on oppositions between protecting health and healthcare systems versus saving livelihoods and the economy, a dichotomy that we argue is false. Drawing on 482 interviews conducted in Germany, Italy, Ireland, Austria, German-speaking Switzerland and the UK over two points in a 6-month period as part of the 'Solidarity in times of Pandemics Research Consortium' (SolPan), we illustrate the ways that oppositions posed between saving lives or saving livelihoods fail to capture the entangled, long-standing nature of structural inequalities that have been revealed through the pandemic. Health- and wealth-related inequalities intersect to produce the "second pandemic," a term used by a research participant to explain the other forms of devastation that run in parallel with virus. Our findings thus complicate such dichotomies through a qualitative understanding of the pandemic as a lived experience. The pandemic emerges as a critical juncture which, in exacerbating these existing structural inequalities, also poses an opportunity to work to better resolve them.

Identifiants

pubmed: 34883310
pii: S0277-9536(21)00966-7
doi: 10.1016/j.socscimed.2021.114634
pmc: PMC8648175
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

114634

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203132/Z/16/Z
Pays : United Kingdom
Organisme : European Research Council
Pays : International

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Références

Soc Sci Med. 2021 Jan;268:113554
pubmed: 33308911
Lancet. 2015 Dec 12;386(10011):2442-4
pubmed: 26364261
Soc Sci Med. 2021 Apr;274:113794
pubmed: 33662772
Eur Child Adolesc Psychiatry. 2022 Jun;31(6):879-889
pubmed: 33492480
BMJ Glob Health. 2020 Jun;5(6):
pubmed: 32527850
Am J Hum Biol. 2020 Sep;32(5):e23482
pubmed: 32754945
J Epidemiol Community Health. 2020 Nov;74(11):964-968
pubmed: 32535550
Gesundheitswesen. 2020 Sep;82(8-09):670-675
pubmed: 32858757
J R Soc Med. 2020 Jun;113(6):234-235
pubmed: 32521203
Soc Sci Med. 2020 Oct;263:113386
pubmed: 33036797

Auteurs

Amelia Fiske (A)

Institute of History and Ethics in Medicine, TUM School of Medicine, Technical University of Munich, Munich, Germany. Electronic address: a.fiske@tum.de.

Ilaria Galasso (I)

College of Business, University College Dublin, Dublin, Ireland.

Johanna Eichinger (J)

Institute of History and Ethics in Medicine, TUM School of Medicine, Technical University of Munich, Munich, Germany; Institute for Biomedical Ethics, University of Basel, Basel, Switzerland.

Stuart McLennan (S)

Institute of History and Ethics in Medicine, TUM School of Medicine, Technical University of Munich, Munich, Germany.

Isabella Radhuber (I)

Department of Political Science, University of Vienna, Vienna, Austria.

Bettina Zimmermann (B)

Institute of History and Ethics in Medicine, TUM School of Medicine, Technical University of Munich, Munich, Germany; Institute for Biomedical Ethics, University of Basel, Basel, Switzerland.

Barbara Prainsack (B)

Department of Political Science, University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH